CAMCEVI KIT (nda211488)- (EQ 42MG BASE)

Generic Name	LEUPROLIDE MESYLATE	Innovator	ACCORD
Dosage	EQ 42MG BASE
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2039-Jan-01	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2024-May-25
GAIN Expiry	None	Drug Complexity	No
Indication	CAMCEVI is a gonadotropin-releasing hormone (GnRH) agonist indicated for the treatment of adult patients with advanced prostate cancer.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 42MG BASE	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of CAMCEVI KIT